Net Cash Provided by (Used in) Operating Activities of Roivant Sciences Ltd. from 30 Jun 2020 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Roivant Sciences Ltd. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 30 Jun 2020 to 30 Jun 2025.
  • Roivant Sciences Ltd. Net Cash Provided by (Used in) Operating Activities for the quarter ending 30 Jun 2025 was $204,383,000, a 6% decline year-over-year.
  • Roivant Sciences Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $839,451,000, a 9.7% decline from 2023.
  • Roivant Sciences Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $765,268,000, a 9.3% increase from 2022.
  • Roivant Sciences Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $843,393,000, a 24% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

Roivant Sciences Ltd. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $204,383,000 -$11,554,000 -6% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q1
Q2 2024 $192,829,000 +$57,103,000 +23% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q1
Q2 2023 $249,932,000 +$2,150,000 +0.85% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q1
Q2 2022 $252,082,000 -$110,912,000 -79% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q1
Q2 2021 $141,170,000 -$30,003,000 -27% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q1
Q2 2020 $111,167,000 01 Apr 2020 30 Jun 2020 10-Q 21 Sep 2021 2021 Q1

Roivant Sciences Ltd. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $839,451,000 -$74,183,000 -9.7% 01 Apr 2024 31 Mar 2025 10-K 29 May 2025 2024 FY
2023 $765,268,000 +$78,125,000 +9.3% 01 Apr 2023 31 Mar 2024 10-K 29 May 2025 2024 FY
2022 $843,393,000 -$165,664,000 -24% 01 Apr 2022 31 Mar 2023 10-K 29 May 2025 2024 FY
2021 $677,729,000 -$125,591,000 -23% 01 Apr 2021 31 Mar 2022 10-K 28 Jun 2023 2023 FY
2020 $552,138,000 01 Apr 2020 31 Mar 2021 10-K 28 Jun 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.